23249 results for "ega"

in 38.03 milliseconds.

• Multi-Region WES of Metastatic Colorectal Cancer

  Study EGAS00001003573

• Single Cell ATAC-Seq on human cord-blood derived HSPC.

  Study EGAS00001004740

• RNA sequencing of AD, MCI and control ONS cells

  Study EGAS00001006594

• Archaeogenomic distinctiveness of the Isthmo-Colombian area

  Study EGAS00001007131

• Targeted Sequencing of Shwachman-Diamond syndrome bone marrow samples

  Study EGAS00001004879

• The Xq22.3 contiguous gene deletion syndrome (ATS-ID)

  Study EGAS00001005354

• Multifocal ileal NETs study WGS normal tissue

  Study EGAS00001005620

• APOBEC mutagenesis in EGFR mutant TKI resistance NSCLCs

  Study EGAS00001005526

• Exome sequencing in CLL re-treated with venetoclax

  Study EGAS00001006158

• Evolutionary histories of breast cancer and related clones

  Study EGAS00001006282

• Whole exome and genome sequencing investigations of perinatal death

  Study EGAS00001006295

• microRNA and isomiR profiling of Stage 1 epithelial ovarian carcinoma

  Study EGAS00001006617

• Frequencies of variants in the Danish population

  Study EGAS00001006786

• Genomic Analysis of a Metastatic Fusion-negative Embryonal Rhabdomyosarcoma

  Study EGAS00001006946

• RNA-seq of PDAC patient-derived xenograft tumors

  Study EGAS00001007070

• Detection of somatic mutations of angioimmunoblastic T-cell lymphoma

  Study EGAS00001007333

• Total_proteome

  TMT-labelled, total proteome profiled

  Dataset EGAD00010002549

• Lyon University Hospital Molecular Endocrinology Laboratory Data Access Committee

  Dac EGAC00001003363

• The Extracellular RNA Quality Control (exRNAQC) study (phase 2)

  Study EGAS00001006499

• The Extracellular RNA Quality Control (exRNAQC) study (phase 1)

  Study EGAS00001005263

• Mesenchymal niche in myelodysplastic hematopoiesis at single cell resolution

  Study EGAS00001007568

• DAC-Clinical Outcomes of Diffuse Large B-Cell Lymphoma patients

  Dac EGAC50000000595

• NK cells in chronic viral hepatitis Data Access Committee

  Dac EGAC50000000530

• Data access committee for sequencing data generated by Wyatt Lab

  Dac EGAC50000000538

• University of Melbourne Centre for Cancer Research (UMCCR) Data Access Committee

  Dac EGAC00001003567

• Gene expression profile of mesothelial cells from peritoneal adhesion biopsies

  Study EGAS00001005749

• Genome-wide gene expression analysis following CRISPRi of transposable elements

  Dac EGAC00001003585

• MD Anderson Data Access Committee: Pembrolizumab in Advanced Rare Cancers

  Dac EGAC50000000860

• AGLCD sequencing data

  sequencing datasets for AGLCD patient

  Dac EGAC50000000852

• MK Clinical Trial DAC

  DAC for MK Clinical Trial Data

  Dac EGAC50000000677

• COVID-19 whole blood transcriptomic analysis

  Study EGAS00001005332

• HUMANOMNIEXPRESS_Genotyping

  samples using Illumina HUMANOMNIEXPRESS

  Dataset EGAD00010000920

• LUMC Department Pathology, Bone and Soft Tissue Tumor Group

  Dac EGAC50000000763

• Phenotype data

  Phenotype and covariates

  Dataset EGAD00001009966

• LUMC Department Cell and Chemistry Biology, Ten Dijke group

  Dac EGAC50000000585

• DAC_TWINS

  DAC related to monozygotic twins discordant for ALS

  Dac EGAC50000000517

• A GWAS of Progression in Multiple Sclerosis

  This is a genome wide association study (GWAS) of disease progression in multiple sclerosis (MS). The study involved a total of 12584 cases recruited from multiple centres around the world and tested at 7.8 million common autosomal single nucleotide variants. The data from the European cases (n=4853) are included in this EGA submission in 10 country specific data sub-sets.

  Study EGAS00001007162

• All you need to know about the new Submitter Portal

  In September we launched new services for all EGA users, including a new version of the former Submitter Portal. Our main objective with this Portal is to transform the metadata submission in a simplified and user-friendly method. Although it is possible to find documentation about the Submitter Portal on our website, we wanted to highlight the new features in this article. Enjoy! Credentials: who needs to create a new user to access the Submitter Portal and who doesn't? Users with an old submission account (ega-box) can already access the new Submitter Portal. If it is the first time that you want to access, it is time to request a submitter role linked to the EGA User. In the form, it is mandatory to explain which type of data you want to deposit, the size of your submission, add any comment you’d like us to read, and manage the EGA Data Processing Agreement (DPA) document. This document should be checked by the legal department of your institution and signed by a person with authority to sign contracts on behalf of the institution. Note that we provide a DPA template for new Users; it can be found and downloaded in the Submitter Request section. With the DPA signed and the Submitter Request sent, it is time to wait for our Helpdesk team to validate the request. Metadata submission now can be collaborative It is possible to add collaborator(s) to your submissions. Only registered EGA Users will appear on the search bar. When adding a collaborator, it is mandatory to define the permission granted: Read only: collaborators with this permission can check if the information of the submission is correct but cannot modify anything. Read & write: collaborators with this label can register new objects and modify the registered ones. We wanted to save time for submitters that usually rely on the same collaborators. For that, we have implemented the possibility of adding the same collaborators from previous submissions; all you need to do is to search the submission, and the exact set of EGA users will have access to your submission. You can check the collaborators and their permissions at any point of the submission by going to the collaborators section. Even adding more people to complete the submission is allowed by following the same steps: looking for the EGA User and defining the permission granted (please, note that during the submission it is not possible to add collaborators from previous submissions). Use external links to complement the study information When filling the information about the study we recommend users to enrich the submission with complementary fields such as PubMeds IDs, custom tags and external links. External links are used to connect a study to an external repository. We have implemented an external link to Euro-Bioimaging for a European Project (EuCanImage). Now, we are looking forward to keeping increasing the list of external repositories! Choose the expected release date for your metadata to be searchable on our website Once all the metadata objects are registered it is time to finalise the submission so that the Helpdesk team can approve it. In the new version of the Submitter Portal users can choose the expected release date for the metadata to be searchable on the EGA website. Please, note that the selected date will have a minimum of one week margin from the day of finalisation. This time is necessary for your files to be archived and for the submission to be validated by the Helpdesk Team. Are you looking for the Array submission within the Submitter Portal? Our Submitter Portal does not support array submissions. The submission of Array-based metadata must be done using the EGA programmatic submission. You will find our Array-based format template and all the necessary information on our website, and you can find all the steps in our submission quickguide! More information about the submission process at the EGA Our Team has developed an extended documentation related to metadata submission. A good first step is to take a closer look at the Submission FAQ. To have a general overview of all the metadata submission process we recommend taking a glimpse of our take-the-tour or watching the tutorial available on our YouTube Channel. Don't miss our section on EGA Schemas, to learn more about how the EGA is built. It can be useful to fully ensure that your submissions comply with the EGA's standards and contribute to a valuable and accessible genomic resource.

  Blog new-submitter-portal

• Helmholtz Centre for Infection Research, Centre for Individualised Medicine

  Dac EGAC00001002303

• UCL Cancer Institute DAC

  Dac EGAC00001001579

• Hematology Research Unit Helsinki Data Access Committee

  Dac EGAC00001002789

• Data Access Commitee of the Kok group, NKI

  Dac EGAC00001003025

• Single-cell TCR sequencing of gluten-specific T cells

  Study EGAS00001003245

• Treated and control Patient Derived Xenografts of colorectal cancer (CRC) samples

  Dac EGAC00001003073

• Gene expression in CSF and blood of patients with pneumococcal meningitis

  Study EGAS00001003355

• Liquid Biopsy Data Access Committee

  Dac EGAC00001002239

• Longitudinal single-cell RNA-seq data of metastatic ovarian cancer

  Study EGAS00001005006

• Data Access Commitee of Nanjing Medical University Affiliated Jiangsu Cancer Hospital

  Dac EGAC00001003206

• Presence of bacterial infection in brains of patients with Huntington's disease

  Dac EGAC00001001222

• Gene expression profile of mesothelial-derived carcinoma-associated fibroblasts Data Access Commitee

  Dac EGAC00001001267

• Genentech DevSci DAC

  Dac EGAC00001003352

• Type 2 Diabetes GoT2D/T2D-GENES DAC

  Dac EGAC00001000391

• DAC for study Exon resequencing in patients with Brugada syndrome

  Dac EGAC00001000006

• DAC: British Columbia Cancer Agency (BCCA), PHSAs Technology Development Office, Data Access Committee

  Dac EGAC00001000122

• GoNL Data Access Committee of BBMRI-NL

  Dac EGAC00001000146

• “Human population genetics” team (Muséum national d’Histoire naturelle, Paris, France)

  Dac EGAC00001000147

• Department of Pediatrics, The University of Tokyo Data Access Committee

  Dac EGAC00001000207

• DAC for the "Study on the proliferation history of colorectal adenomas"

  Dac EGAC00001000209

• Molecular and Population Genetics (MPG) research at ICR DAC agreement

  Dac EGAC00001000303

• Department of Pathology and Tumor Biology, Kyoto University Data Access Committee

  Dac EGAC00001000327

• DAC of Synergie Lyon Cancer

  Dac EGAC00001000382

• DAC for study Population Structure and Genetic Diversity in Argentinean populations

  Dac EGAC00001000426

• DAC-Genomics&Disease

  Dac EGAC00001000438

• DAC of the chronic lymphocytic leukemia epigenome and transcriptome profiling project

  Dac EGAC00001000486

• DAC for genome-wide association study of prognosis in Crohn's disease

  Dac EGAC00001000568

• Identification of fungal species in brain of AD patients by NGS

  Dac EGAC00001000593

• DAC for study Treg in breast cancer and healthy individuals

  Dac EGAC00001000638

• DAC for NKTL study. National Cancer Centre Singapore.

  Dac EGAC00001000640

• JKU and MUI Data Access Committee for targeted NGS panel data

  Dac EGAC00001000669

• Clonal evolution study of Intrahepatic cholangiocarcinoma: 69 PDPCs and 6 tissues.

  Dac EGAC00001000718

• DAC for the family-based genome-wide association study on CRSwNP

  Dac EGAC00001000742

• Data Access Committee (DAC) for NGS-based T-PLL data

  Dac EGAC00001000784

• K.G. Jebsen Coeliac Disease Research Centre, University of Oslo, Norway

  Dac EGAC00001000848

• Stanford Data Access Committee for Breast Cancer Tumor Heterogeneity through Treatment

  Dac EGAC00001000993

• Genome-wide association study of cervical cancer in East Asian populations

  Dac EGAC00001001024

• University Clinic Erlangen/ German Cancer Research Center rare tumors data access committee

  Dac EGAC00001001053

• DAC to control data accession to the Myeloproliferative Neoplasm transcriptome study

  Dac EGAC00001001134

• Department of Pathology and Tumor Biology, Kyoto University Data Access Committee

  Dac EGAC00001001140

• Guangzhou Medical University LAM Data Access Committee

  Dac EGAC00001001148

• Data Access Committee for Rare Coding Variants in Lupus Risk Genes

  Dac EGAC00001001157

• Data Access Committee of Institute of Molecular and Translational Medicine

  Dac EGAC00001001172

• Transcriptomics of dried blood spots in ELGANs Barcelona study

  Dac EGAC00001001193

• DAC for TCR-seq analysis of human intestinal Trm cells

  Dac EGAC00001001219

• Department of Pathology and Tumor Biology, Kyoto University Data Access Committee

  Dac EGAC00001001232

• Department of Pathology and Tumor Biology, Kyoto University Data Access Committee

  Dac EGAC00001001235

• High-grade serous ovarian cancer (MDACC) data access committee

  Dac EGAC00001001288

• Department of Pathology and Tumor Biology, Kyoto University Data Access Committee

  Dac EGAC00001001292

• Department of Pathology and Tumor Biology, Kyoto University Data Access Committee

  Dac EGAC00001001299

• Department of Pathology and Tumor Biology, Kyoto University Data Access Committee

  Dac EGAC00001001356

• MS Risk Gene Data Access Committee

  Dac EGAC00001001416

• Department of Pathology and Tumor Biology, Kyoto University Data Access Committee

  Dac EGAC00001001459

• DAC for Sex-biased patterns shaped the genetic history of Roma

  Dac EGAC00001001477

• Single Cell RNAseq of blood and tumor from renal cancer patients

  Dac EGAC00001001494

• Pediatric Low-Grade Glioma Sequencing Data Access Committee

  Dac EGAC00001001498

• Total RNAseq in the sporadic ALS and healthy control motor cortex

  Dac EGAC00001001515

• Institut National pour la Recherche Biomedicale Comite d'Access aux Donnees

  Dac EGAC00001001539

• Department of Pathology and Tumor Biology, Kyoto University Data Access Committee

  Dac EGAC00001001542

• BIH COVID-19 airway single-cell data access committee.

  Dac EGAC00001001627

• MOMA - Bladder group DAC

  Dac EGAC00001001642

• NKI (Netherlands Cancer Institute)

  Dac EGAC00001001648